Skip to content

DBV Technologies DBVT Asset turnover

Asset turnover at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-0.1×
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
0.0×
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
0.1×-0.2×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
0.0×
Alumis Inc. logo
Alumis Inc.ALMS
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+269%
Enterprise value$700.21M+188%
P/S159.6×+89.0×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Calculated from DBV Technologies’s reported figures.

Based on trailing twelve months.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's asset turnover?
DBV Technologies (DBVT) reported asset turnover of 0× in Q1 2026.
How has DBV Technologies's asset turnover changed year-over-year?
DBV Technologies's asset turnover increased by 1.1% year-over-year, from 0× to 0×.
What is the long-term trend for DBV Technologies's asset turnover?
Over 3 years (2021 to 2025), DBV Technologies's asset turnover has grown at a 11.8% compound annual growth rate (CAGR), from 0× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.